TRANSLOCATION RENAL CELL CARCINOMA
Clinical trials for TRANSLOCATION RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new TRANSLOCATION RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for TRANSLOCATION RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Supercharged immune cells take on Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests whether a new immune cell therapy called CIML NK cells, combined with a low dose of IL-2, is safe and feasible for people with advanced kidney or bladder cancers. The therapy uses a patient's own immune cells that are trained in a lab to better recogn…
Matched conditions: TRANSLOCATION RENAL CELL CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 17, 2026 02:14 UTC
-
Triple-Drug cocktail targets rare kidney cancers
Disease control OngoingThis study tests whether a combination of three drugs (cabozantinib, nivolumab, and ipilimumab) can safely slow the growth of advanced or spreading kidney cancer in people with rare types of the disease. About 60 adults with non-clear cell kidney cancer that cannot be surgically …
Matched conditions: TRANSLOCATION RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Bradley A. McGregor, MD • Aim: Disease control
Last updated May 13, 2026 16:03 UTC